The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antimicrobial Susceptibility Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Antimicrobial Susceptibility Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antimicrobial Susceptibility Testing market size is estimated to be worth US$ 2540.2 million in 2021 and is forecast to a readjusted size of USD 3075.1 million by 2028 with a CAGR of 2.8% during review period. Clinical Diagnostics accounting for % of the Antimicrobial Susceptibility Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antibacterial Susceptibility Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Antimicrobial Susceptibility Testing include Biomérieux, Danaher, BD, Thermo Fisher, and Bio-Rad, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antimicrobial Susceptibility Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing
Market segment by Application, can be divided into
Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications
Market segment by players, this report covers
Biomérieux
Danaher
BD
Thermo Fisher
Bio-Rad
Hi-Media
Merlin
Liofilchem
Accelerate Diagnostics
Alifax
Creative Diagnostics
Merck Group
Synbiosis
Bioanalyse
Zhuhai Dl Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Antimicrobial Susceptibility Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Antimicrobial Susceptibility Testing, with revenue, gross margin and global market share of Antimicrobial Susceptibility Testing from 2019 to 2022.
Chapter 3, the Antimicrobial Susceptibility Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Antimicrobial Susceptibility Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Antimicrobial Susceptibility Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
The Antimicrobial Susceptibility Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antimicrobial Susceptibility Testing market size is estimated to be worth US$ 2540.2 million in 2021 and is forecast to a readjusted size of USD 3075.1 million by 2028 with a CAGR of 2.8% during review period. Clinical Diagnostics accounting for % of the Antimicrobial Susceptibility Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antibacterial Susceptibility Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Antimicrobial Susceptibility Testing include Biomérieux, Danaher, BD, Thermo Fisher, and Bio-Rad, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antimicrobial Susceptibility Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing
Market segment by Application, can be divided into
Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications
Market segment by players, this report covers
Biomérieux
Danaher
BD
Thermo Fisher
Bio-Rad
Hi-Media
Merlin
Liofilchem
Accelerate Diagnostics
Alifax
Creative Diagnostics
Merck Group
Synbiosis
Bioanalyse
Zhuhai Dl Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Antimicrobial Susceptibility Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Antimicrobial Susceptibility Testing, with revenue, gross margin and global market share of Antimicrobial Susceptibility Testing from 2019 to 2022.
Chapter 3, the Antimicrobial Susceptibility Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Antimicrobial Susceptibility Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Antimicrobial Susceptibility Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Antimicrobial Susceptibility Testing
1.2 Classification of Antimicrobial Susceptibility Testing by Type
1.2.1 Overview: Global Antimicrobial Susceptibility Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Antimicrobial Susceptibility Testing Revenue Market Share by Type in 2021
1.2.3 Antibacterial Susceptibility Testing
1.2.4 Antifungal Susceptibility Testing
1.2.5 Antiparasitic Susceptibility Testing
1.2.6 Other Susceptibility Testing
1.3 Global Antimicrobial Susceptibility Testing Market by Application
1.3.1 Overview: Global Antimicrobial Susceptibility Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery and Development
1.3.4 Epidemiology
1.3.5 Other Applications
1.4 Global Antimicrobial Susceptibility Testing Market Size & Forecast
1.5 Global Antimicrobial Susceptibility Testing Market Size and Forecast by Region
1.5.1 Global Antimicrobial Susceptibility Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Antimicrobial Susceptibility Testing Market Size by Region, (2017-2022)
1.5.3 North America Antimicrobial Susceptibility Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Antimicrobial Susceptibility Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Antimicrobial Susceptibility Testing Market Size and Prospect (2017-2028)
1.5.6 South America Antimicrobial Susceptibility Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Antimicrobial Susceptibility Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antimicrobial Susceptibility Testing Market Drivers
1.6.2 Antimicrobial Susceptibility Testing Market Restraints
1.6.3 Antimicrobial Susceptibility Testing Trends Analysis
2 Company Profiles
2.1 Biomérieux
2.1.1 Biomérieux Details
2.1.2 Biomérieux Major Business
2.1.3 Biomérieux Antimicrobial Susceptibility Testing Product and Solutions
2.1.4 Biomérieux Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Biomérieux Recent Developments and Future Plans
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Antimicrobial Susceptibility Testing Product and Solutions
2.2.4 Danaher Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Danaher Recent Developments and Future Plans
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Antimicrobial Susceptibility Testing Product and Solutions
2.3.4 BD Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BD Recent Developments and Future Plans
2.4 Thermo Fisher
2.4.1 Thermo Fisher Details
2.4.2 Thermo Fisher Major Business
2.4.3 Thermo Fisher Antimicrobial Susceptibility Testing Product and Solutions
2.4.4 Thermo Fisher Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Thermo Fisher Recent Developments and Future Plans
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business
2.5.3 Bio-Rad Antimicrobial Susceptibility Testing Product and Solutions
2.5.4 Bio-Rad Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Bio-Rad Recent Developments and Future Plans
2.6 Hi-Media
2.6.1 Hi-Media Details
2.6.2 Hi-Media Major Business
2.6.3 Hi-Media Antimicrobial Susceptibility Testing Product and Solutions
2.6.4 Hi-Media Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Hi-Media Recent Developments and Future Plans
2.7 Merlin
2.7.1 Merlin Details
2.7.2 Merlin Major Business
2.7.3 Merlin Antimicrobial Susceptibility Testing Product and Solutions
2.7.4 Merlin Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Merlin Recent Developments and Future Plans
2.8 Liofilchem
2.8.1 Liofilchem Details
2.8.2 Liofilchem Major Business
2.8.3 Liofilchem Antimicrobial Susceptibility Testing Product and Solutions
2.8.4 Liofilchem Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Liofilchem Recent Developments and Future Plans
2.9 Accelerate Diagnostics
2.9.1 Accelerate Diagnostics Details
2.9.2 Accelerate Diagnostics Major Business
2.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Product and Solutions
2.9.4 Accelerate Diagnostics Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Accelerate Diagnostics Recent Developments and Future Plans
2.10 Alifax
2.10.1 Alifax Details
2.10.2 Alifax Major Business
2.10.3 Alifax Antimicrobial Susceptibility Testing Product and Solutions
2.10.4 Alifax Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Alifax Recent Developments and Future Plans
2.11 Creative Diagnostics
2.11.1 Creative Diagnostics Details
2.11.2 Creative Diagnostics Major Business
2.11.3 Creative Diagnostics Antimicrobial Susceptibility Testing Product and Solutions
2.11.4 Creative Diagnostics Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Creative Diagnostics Recent Developments and Future Plans
2.12 Merck Group
2.12.1 Merck Group Details
2.12.2 Merck Group Major Business
2.12.3 Merck Group Antimicrobial Susceptibility Testing Product and Solutions
2.12.4 Merck Group Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Merck Group Recent Developments and Future Plans
2.13 Synbiosis
2.13.1 Synbiosis Details
2.13.2 Synbiosis Major Business
2.13.3 Synbiosis Antimicrobial Susceptibility Testing Product and Solutions
2.13.4 Synbiosis Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Synbiosis Recent Developments and Future Plans
2.14 Bioanalyse
2.14.1 Bioanalyse Details
2.14.2 Bioanalyse Major Business
2.14.3 Bioanalyse Antimicrobial Susceptibility Testing Product and Solutions
2.14.4 Bioanalyse Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Bioanalyse Recent Developments and Future Plans
2.15 Zhuhai Dl Biotech
2.15.1 Zhuhai Dl Biotech Details
2.15.2 Zhuhai Dl Biotech Major Business
2.15.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Product and Solutions
2.15.4 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Zhuhai Dl Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antimicrobial Susceptibility Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Antimicrobial Susceptibility Testing Players Market Share in 2021
3.2.2 Top 10 Antimicrobial Susceptibility Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Antimicrobial Susceptibility Testing Players Head Office, Products and Services Provided
3.4 Antimicrobial Susceptibility Testing Mergers & Acquisitions
3.5 Antimicrobial Susceptibility Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Antimicrobial Susceptibility Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Antimicrobial Susceptibility Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Antimicrobial Susceptibility Testing Revenue Market Share by Application (2017-2022)
5.2 Global Antimicrobial Susceptibility Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
6.2 North America Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
6.3 North America Antimicrobial Susceptibility Testing Market Size by Country
6.3.1 North America Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
6.3.2 United States Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
7.2 Europe Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
7.3 Europe Antimicrobial Susceptibility Testing Market Size by Country
7.3.1 Europe Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
7.3.2 Germany Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
7.3.3 France Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Antimicrobial Susceptibility Testing Market Size by Region
8.3.1 Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Region (2017-2028)
8.3.2 China Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
8.3.5 India Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
9.2 South America Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
9.3 South America Antimicrobial Susceptibility Testing Market Size by Country
9.3.1 South America Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
9.3.2 Brazil Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Antimicrobial Susceptibility Testing Market Size by Country
10.3.1 Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
10.3.2 Turkey Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Antimicrobial Susceptibility Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Antimicrobial Susceptibility Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Antimicrobial Susceptibility Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Antimicrobial Susceptibility Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Antimicrobial Susceptibility Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Antimicrobial Susceptibility Testing Revenue Market Share by Region (2023-2028)
Table 6. Biomérieux Corporate Information, Head Office, and Major Competitors
Table 7. Biomérieux Major Business
Table 8. Biomérieux Antimicrobial Susceptibility Testing Product and Solutions
Table 9. Biomérieux Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Danaher Corporate Information, Head Office, and Major Competitors
Table 11. Danaher Major Business
Table 12. Danaher Antimicrobial Susceptibility Testing Product and Solutions
Table 13. Danaher Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BD Corporate Information, Head Office, and Major Competitors
Table 15. BD Major Business
Table 16. BD Antimicrobial Susceptibility Testing Product and Solutions
Table 17. BD Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Major Business
Table 20. Thermo Fisher Antimicrobial Susceptibility Testing Product and Solutions
Table 21. Thermo Fisher Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 23. Bio-Rad Major Business
Table 24. Bio-Rad Antimicrobial Susceptibility Testing Product and Solutions
Table 25. Bio-Rad Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Hi-Media Corporate Information, Head Office, and Major Competitors
Table 27. Hi-Media Major Business
Table 28. Hi-Media Antimicrobial Susceptibility Testing Product and Solutions
Table 29. Hi-Media Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Merlin Corporate Information, Head Office, and Major Competitors
Table 31. Merlin Major Business
Table 32. Merlin Antimicrobial Susceptibility Testing Product and Solutions
Table 33. Merlin Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Liofilchem Corporate Information, Head Office, and Major Competitors
Table 35. Liofilchem Major Business
Table 36. Liofilchem Antimicrobial Susceptibility Testing Product and Solutions
Table 37. Liofilchem Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Accelerate Diagnostics Corporate Information, Head Office, and Major Competitors
Table 39. Accelerate Diagnostics Major Business
Table 40. Accelerate Diagnostics Antimicrobial Susceptibility Testing Product and Solutions
Table 41. Accelerate Diagnostics Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Alifax Corporate Information, Head Office, and Major Competitors
Table 43. Alifax Major Business
Table 44. Alifax Antimicrobial Susceptibility Testing Product and Solutions
Table 45. Alifax Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Creative Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Creative Diagnostics Major Business
Table 48. Creative Diagnostics Antimicrobial Susceptibility Testing Product and Solutions
Table 49. Creative Diagnostics Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Merck Group Corporate Information, Head Office, and Major Competitors
Table 51. Merck Group Major Business
Table 52. Merck Group Antimicrobial Susceptibility Testing Product and Solutions
Table 53. Merck Group Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Synbiosis Corporate Information, Head Office, and Major Competitors
Table 55. Synbiosis Major Business
Table 56. Synbiosis Antimicrobial Susceptibility Testing Product and Solutions
Table 57. Synbiosis Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Bioanalyse Corporate Information, Head Office, and Major Competitors
Table 59. Bioanalyse Major Business
Table 60. Bioanalyse Antimicrobial Susceptibility Testing Product and Solutions
Table 61. Bioanalyse Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Zhuhai Dl Biotech Corporate Information, Head Office, and Major Competitors
Table 63. Zhuhai Dl Biotech Major Business
Table 64. Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Product and Solutions
Table 65. Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Antimicrobial Susceptibility Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Antimicrobial Susceptibility Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Antimicrobial Susceptibility Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Antimicrobial Susceptibility Testing Players Head Office, Products and Services Provided
Table 70. Antimicrobial Susceptibility Testing Mergers & Acquisitions in the Past Five Years
Table 71. Antimicrobial Susceptibility Testing New Entrants and Expansion Plans
Table 72. Global Antimicrobial Susceptibility Testing Revenue (USD Million) by Type (2017-2022)
Table 73. Global Antimicrobial Susceptibility Testing Revenue Share by Type (2017-2022)
Table 74. Global Antimicrobial Susceptibility Testing Revenue Forecast by Type (2023-2028)
Table 75. Global Antimicrobial Susceptibility Testing Revenue by Application (2017-2022)
Table 76. Global Antimicrobial Susceptibility Testing Revenue Forecast by Application (2023-2028)
Table 77. North America Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Antimicrobial Susceptibility Testing Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Antimicrobial Susceptibility Testing Picture
Figure 2. Global Antimicrobial Susceptibility Testing Revenue Market Share by Type in 2021
Figure 3. Antibacterial Susceptibility Testing
Figure 4. Antifungal Susceptibility Testing
Figure 5. Antiparasitic Susceptibility Testing
Figure 6. Other Susceptibility Testing
Figure 7. Antimicrobial Susceptibility Testing Revenue Market Share by Application in 2021
Figure 8. Clinical Diagnostics Picture
Figure 9. Drug Discovery and Development Picture
Figure 10. Epidemiology Picture
Figure 11. Other Applications Picture
Figure 12. Global Antimicrobial Susceptibility Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Antimicrobial Susceptibility Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Antimicrobial Susceptibility Testing Revenue Market Share by Region (2017-2028)
Figure 15. Global Antimicrobial Susceptibility Testing Revenue Market Share by Region in 2021
Figure 16. North America Antimicrobial Susceptibility Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Antimicrobial Susceptibility Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Antimicrobial Susceptibility Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Antimicrobial Susceptibility Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Antimicrobial Susceptibility Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Antimicrobial Susceptibility Testing Market Drivers
Figure 22. Antimicrobial Susceptibility Testing Market Restraints
Figure 23. Antimicrobial Susceptibility Testing Market Trends
Figure 24. Biomérieux Recent Developments and Future Plans
Figure 25. Danaher Recent Developments and Future Plans
Figure 26. BD Recent Developments and Future Plans
Figure 27. Thermo Fisher Recent Developments and Future Plans
Figure 28. Bio-Rad Recent Developments and Future Plans
Figure 29. Hi-Media Recent Developments and Future Plans
Figure 30. Merlin Recent Developments and Future Plans
Figure 31. Liofilchem Recent Developments and Future Plans
Figure 32. Accelerate Diagnostics Recent Developments and Future Plans
Figure 33. Alifax Recent Developments and Future Plans
Figure 34. Creative Diagnostics Recent Developments and Future Plans
Figure 35. Merck Group Recent Developments and Future Plans
Figure 36. Synbiosis Recent Developments and Future Plans
Figure 37. Bioanalyse Recent Developments and Future Plans
Figure 38. Zhuhai Dl Biotech Recent Developments and Future Plans
Figure 39. Global Antimicrobial Susceptibility Testing Revenue Share by Players in 2021
Figure 40. Antimicrobial Susceptibility Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Antimicrobial Susceptibility Testing Revenue Market Share in 2021
Figure 42. Global Top 10 Players Antimicrobial Susceptibility Testing Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Antimicrobial Susceptibility Testing Revenue Share by Type in 2021
Figure 45. Global Antimicrobial Susceptibility Testing Market Share Forecast by Type (2023-2028)
Figure 46. Global Antimicrobial Susceptibility Testing Revenue Share by Application in 2021
Figure 47. Global Antimicrobial Susceptibility Testing Market Share Forecast by Application (2023-2028)
Figure 48. North America Antimicrobial Susceptibility Testing Sales Market Share by Type (2017-2028)
Figure 49. North America Antimicrobial Susceptibility Testing Sales Market Share by Application (2017-2028)
Figure 50. North America Antimicrobial Susceptibility Testing Revenue Market Share by Country (2017-2028)
Figure 51. United States Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Antimicrobial Susceptibility Testing Sales Market Share by Type (2017-2028)
Figure 55. Europe Antimicrobial Susceptibility Testing Sales Market Share by Application (2017-2028)
Figure 56. Europe Antimicrobial Susceptibility Testing Revenue Market Share by Country (2017-2028)
Figure 57. Germany Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Antimicrobial Susceptibility Testing Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Antimicrobial Susceptibility Testing Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Antimicrobial Susceptibility Testing Revenue Market Share by Region (2017-2028)
Figure 65. China Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Antimicrobial Susceptibility Testing Sales Market Share by Type (2017-2028)
Figure 72. South America Antimicrobial Susceptibility Testing Sales Market Share by Application (2017-2028)
Figure 73. South America Antimicrobial Susceptibility Testing Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Antimicrobial Susceptibility Testing Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Antimicrobial Susceptibility Testing Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Antimicrobial Susceptibility Testing Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Antimicrobial Susceptibility Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
